The relationship between hospital or operator volume and outcomes of coronary patients undergoing percutaneous coronary interventions

Zeitschrift fur Kardiologie

Volumn 94, Issue 4, 2005, Pages 231-238

  Dibra, A ^a   Kastrati, A ^a   Schuhlen H ^b   Schomig A ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Experience; Outcome; Percutaneous coronary intervention

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ANGIOPLASTY; CORONARY ARTERY BYPASS SURGERY; CORONARY STENT; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH INSURANCE; HEART SURGERY; HOSPITAL ADMISSION; HOSPITAL COST; HUMAN; ISCHEMIC HEART DISEASE; MEDICARE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PHYSICIAN; POSTOPERATIVE COMPLICATION; QUALITY OF LIFE; REVIEW; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERIOSCLEROSIS; HOSPITAL MORTALITY; HOSPITALS; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PHYSICIANS; STATISTICS; TREATMENT OUTCOME;

EID: 17744394065     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00392-005-0206-5     Document Type: Review

References (52)

1. Luft HS, Bunker JP, Enthoven AC (1979) Should operations be regionalized? The empirical relation between surgical volume and mortality. N Engl J Med 301:1364-1369
2. Bunker JP, Luft HS, Enthoven A (1982) Should surgery be regionalized? Surg Clin North Am 62:657-668
3. Luft HS, Hunt SS, Maerki SC (1987) The volume-outcome relationship: practice-makes-perfect or selective-referral patterns? Health Serv Res 22:157-182
4. Flood AB, Scott WR, Ewy W (1984) Does practice make perfect? Part II: the relation between volume and outcomes and other hospital characteristics. Med Care 22:115-125
5. Hannan EL (1999) The relation between volume and outcome in health care. N Engl J Med 340:1677-1679
6. Dudley RA, Johansen KL, Brand R, Rennie DJ, Milstein A (2000) Selective referral to high-volume hospitals: estimating potentially avoidable deaths. JAMA 283:1159-1166
7. Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL (2003) Surgeon volume and operative mortality in the United States. N Engl J Med 349:2117-2127
8. Magid DJ, Calonge BN, Rumsfeld JS, Canto JG, Frederick PD, Every NR, Barron HV (2000) Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs thrombolytic therapy. JAMA 284:3131-3138
9. The Leapfrog group. Fact sheet. Accessed July 2004: http://www.leapfrog group.org/purchase.htm
10. Center for Medical Consumers. Accessed July 2004: http://www. medicalconsumers.org.
11. HealthScope Hospital Ratings. Accessed July 2004: http://www.healthscope. org/Interface/ hospitals/default.asp.
12. The Pacific Business Groupon Health. Accessed July 2004: http://www.pbgh.org/
13. Luft HS (1980) The relation between surgical volume and mortality: an exploration of causal factors and alternative models. Med Care 18:940-959
14. Flood AB, Scott WR, Ewy W (1984) Does practice make perfect? Part I: The relation between hospital volume and outcomes for selected diagnostic categories. Med Care 22:98-114
15. Kizer KW (2003) The volume-outcome conundrum. N Engl J Med 349:2159-2161
16. Hannan EL, Wu C, Ryan TJ, Bennett E, Culliford AT, Gold JP, Hartman A, Isom OW, Jones RH, McNeil B (2003) Do hospitals and surgeons with higher coronary artery bypass graft surgery volumes still have lower risk-adjusted mortality rates? Circulation 108:795-801
17. Goodney PP, Lucas FL, Birkmeyer JD (2003) Should volume standards for cardiovascular surgery focus only on high-risk patients? Circulation 107:384-387
18. Hoh BL, Rabinov JD, Pryor JC, Carter BS, Barker FG, 2nd (2003) In-hospital morbidity and mortality after endovascular treatment of unruptured intracranial aneurysms in the United States, 1996-2000: effect of hospital and physician volume. AJNR Am J Neuroradiol 24:1409-1420
19. Birkmeyer JD (2000) High-risk surgery - follow the crowd. JAMA 283:1191-1193
20. Ritchie JL, Phillips KA, Luft HS (1993) Coronary angioplasty. Statewide experience in California. Circulation 88:2735-2743
21. Phillips KA, Luft HS, Ritchie JL (1995) The association of hospital volumes of percutaneous transluminal coronary angioplasty with adverse outcomes, length of stay, and charges in California. Med Care 33:502-514
22. Jollis JG, Peterson ED, DeLong ER, Mark DB, Collins SR, Muhlbaier LH, Pryor DB (1994) The relation between the volume of coronary angioplasty procedures at hospitals treating MEDICARE beneficiaries and short-term mortality. N Engl J Med 331:1625-1629
23. Hannan EL, Racz M, Ryan TJ, McCallister BD, Johnson LW, Arani DT, Guerci AD, Sosa J, Topol EJ (1997) Coronary angioplasty volume-outcome relationships for hospitals and cardiologists. JAMA 277:892-898
24. Maynard C, Every NR, Chapko MK, Ritchie JL (1999) Institutional volumes and coronary angioplasty outcomes before and after the introduction of stenting. Eff Clin Pract 2:108-113
25. Al Suwaidi J, Velianou JL, Berger PB, Mathew V, Garratt KN, Reeder GS, Grill DE, Holmes DR Jr (2001) Primary percutaneous coronary interventions in patients with acute myocardial infarction and prior coronary artery bypass grafting. Am Heart J 142:452-459
26. Brindis RG, Weintraub WS, Dudley RA (2003) Volume as a surrogate for percutaneous coronary intervention quality: is this the right measuring stick? Am Heart J 146:932-934
27. Malenka DJ, McGrath PD, Wennberg DE, Ryan TJ Jr, Kellett MA Jr, Shubrooks SJ Jr, Bradley WA, Hettlemen BD, Robb JE, Hearne MJ (1999) The relationship between operator volume and outcomes after percutaneous coronary interventions in high volume hospitals in 1994-1996: the northern New England experience. Northern New England Cardiovascular Disease Study Group. J Am Coll Cardiol 34:1471-1480
28. Maynard C, Every NR, Chapko MK, Ritchie JL (2001) Improved outcomes associated with stenting in the healthcare cost and utilization project. J Interv Cardiol 14:159-163
29. Rill V, Brown DL (1999) Practice of coronary angioplasty in California in 1995: comparison to 1989 and impact of coronary stenting. Circulation 99:e1209
30. Kastrati A, Neumann FJ, Schömig A (1998) Operator volume and outcome of patients undergoing coronary stent placement. J Am Coll Cardiol 32:970-976
31. McGrath PD, Wennberg DE, Dickens JD Jr, Siewers AE, Lucas FL, Malenka DJ, Kellett MA Jr, Ryan TJ Jr (2000) Relation between operator and hospital volume and outcomes following percutaneous coronary interventions in the era of the coronary stent. JAMA 284:3139-3144
32. Brown DL (2003) Analysis of the institutional volume-outcome relations for balloon angioplasty and stenting in the stent era in California. Am Heart J 146:1071-1076
33. Kastrati A, Mehilli J, Dirschinger J, Schricke U, Neverve J, Pache J, Martinoff S, Neumann FJ, Nekolla S, Blasini R (2002) Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial. Lancet 359:920-925
34. Grines C, Patel A, Zijlstra F, Weaver WD, Granger C, Simes RJ (2003) Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: six-month follow up and analysis of individual patient data from randomized trials. Am Heart J 145:47-57
35. Andersen HR, Nielsen TT, Rasmussen K, Thuesen L, Kelbaek H, Thayssen P, Abildgaard U, Pedersen F, Madsen JK, Grande P (2003) A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 349:733-742
36. Vakili BA, Kaplan R, Brown DL (2001) Volume-outcome relation for physicians and hospitals performing angioplasty for acute myocardial infarction in New York state. Circulation 104:2171-2176
37. Schömig A, Ndrepepa G, Mehilli J, Schwaiger M, Schühlen H, Nekolla S, Pache J, Martinoff S, Bollwein H, Kastrati A (2003) Therapy-dependent influence of time-to-treatment interval on myocardial salvage in patients with acute myocardial infarction treated with coronary artery stenting or thrombolysis. Circulation 108:1084-1088
38. Ndrepepa G, Mehilli J, Schwaiger M, Schuhlen H, Nekolla S, Martinoff S, Schmitt C, Dirschinger J, Schomig A, Kastrati A (2004) Prognostic value of myocardial salvage achieved by reperfusion therapy in patients with acute myocardial infarction. J Nucl Med 45:725-729
39. Jacobs AK (2003) Primary angioplasty for acute myocardial infarction - is it worth the wait? N Engl J Med 349:798-800
40. Chen EW, Canto JG, Parsons LS, Peterson ED, Littrell KA, Every NR, Gibson CM, Hochman JS, Ohman EM, Cheeks M (2003) Relation between hospital intra-aortic balloon counterpulsation volume and mortality in acute myocardial infarction complicated by cardiogenic shock. Circulation 108:951-957
41. Smith SC Jr, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ, Kuntz RE, Popma JJ, Schaff HV, Williams DO (2001) ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines) - executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty). J Am Coll Cardiol 37:2215-2239
42. Birkmeyer JD, Finlayson EV, Birkmeyer CM (2001) Volume standards for high-risk surgical procedures: potential benefits of the Leapfrog initiative. Surgery 130:415-422
43. Vogt A (2004) Trainingsvoraussetzungen und Mindestmengen. Z Kardiol 93:(Suppl 3):H943
44. Shook TL, Sun GW, Burstein S, Eisenhauer AC, Matthews RV (1996) Comparison of percutaneous transluminal coronary angioplasty outcome and hospital costs for low-volume and high-volume operators. Am J Cardiol 77:331-336
45. Frankle S, Keim M, Haller C (2004) Acute sialadenitis after percutaneous coronary intervention. Z Kardiol 93:558-559
46. Zahn R, Fraiture B, Siegler KE, Schneider S, Gitt AK, Seidl K, Gandjour A, Wendland G, Vogt S, Lauterbach KW (2003) Effectiveness of the glycoprotein IIb/IIIa antagonist abciximab during percutaneous coronary interventions (PCI) in clinical practice at a single high-volume center. Z Kardiol 92:438-444
47. Meyners W, Peters S, Trummel M, Koehler B (2004) Successful recanalization of an occluded coronary artery by percutaneous coronary intervention, systemic administration of tirofiban, a glycoprotein IIb/IIIa inhibitor, and intracoronary thrombolysis with alteplase. Z Kardiol 93:407-412
48. Mark B, Schneider S, Schiele R, Taubert G, Kilkowski C, Seidl K, Nagel D, Seiler D, Senges J, Zahn R (2003) Comparison of different cardiac markers in monitoring percutaneous coronary interventions with frequent use of stents and gpIIbIIIa-antagonists. Z Kardiol 92:1018-1024
49. Rogers WJ, Canto JG, Lambrew CT, Tiefenbrunn AJ, Kinkaid B, Shoultz DA, Frederick PD, Every N (2000) Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. J Am Coll Cardiol 36:2056-2063
50. Zahn R, Schiele R, Schneider S, Gitt AK, Wienbergen H, Seidl K, Bossaller C, Buttner HJ, Gottwik M, Altmann E (2000) Decreasing hospital mortality between 1994 and 1998 in patients with acute myocardial infarction treated with primary angioplasty but not in patients treated with intravenous thrombolysis. Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Registry and the Myocardial Infarction Registry (MIR). J Am Coll Cardiol 36:2064-2071
51. Thiemann DR, Coresh J, Oetgen WJ, Powe NR (1999) The association between hospital volume and survival after acute myocardial infarction in elderly patients. N Engl J Med 340:1640-1648
52. Canto JG, Every NR, Magid DJ, Rogers WJ, Malmgren JA, Frederick PD, French WJ, Tiefenbrunn AJ, Misra VK, Kiefe CI (2000) The volume of primary angioplasty procedures and survival after acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators. N Engl J Med 342:1573-1580